As of Jun 23
| +0.24 / +4.12%|
The 6 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 1.40. The median estimate represents a -9.24% decrease from the last price of 6.06.
The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.